Revealing True Functional Biology to Accelerate Research and Medicine
Our Single Cell Proteomics have uncovered a range of unique biological insights that are illuminating the underlying drivers of complex disease. We provide an automated suite of life sciences products and are powering the future of advanced medicines to fight these diseases.
Unique Proteomic Products:
Our single-cell proteomics and ultra small volume omic products (omics = highly multiplexed) are revealing a direct view into functional biology, to power researchers’ most important work
New Product Updates and Customer Stories
New Publications View All
- Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19
- Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity
- Multi-omic single-cell snapshots reveal multiple independent trajectories to drug tolerance in a melanoma cell line
IsoSpeak Tour
Take the virtual tour of IsoSpeak, our powerful yet easy to use end-to-end software suite.
Uniquely Defining Single-Cell Functional Proteomics
Our functional phenotyping provides a direct view into each single cell’s highly multiplexed secretome or intracellular proteome
Single cell differences typically defined by surface phenotype or genotype- IsoPlexis unique omics: Cell differences by extracellular or intracellular functional phenotype
- Impact: Customers Publishing ability to predict response and accelerate medicines using improved understanding of a variety of cell types
1
1
Functional PhenotypeSC Secretome
2
Functional PhenotypeSC Intracellular Proteome
80+ Publications Highlight Unique and Breakthrough Applications
The IsoLight is the Hub for All of Your Proteomic Applications
Multiple Chip Products: Many Applications
CodePlex Secretome 
Single-Cell Intracellular Proteome 
CodePlex Intracellular Proteome 
Single-Cell Metabolome The IsoLight
Meet your lab’s daily proteomic needs through automation & software that provides ease of use
IsoSpeak Software
Automatically translate biomarkers and utilize intuitive visualizations to understand correlations in vivo
Traditional Workflow
Multiple Instruments Needed
Multiple Manual Workflow Steps
Automate Your Entire Workflow With One System
The IsoLight
Join our global user community,
invent the future of medicine
“Quality assays are mainly descriptive with some objective parameters like cytokine production, cytotoxicity, and proliferation. Only recently, with PSI… can we start to differentiate products.”
Moffitt Cancer Center
“As a cancer research center with a key focus on CAR-T and other cell therapies, we feel that IsoPlexis will enable us to better characterize response and potentially predict whether cancer patients will respond to CAR-T therapy before treatment.”
City of Hope
“Current assays that rely on a single-plex ELISA or even multiparametric flow cytometry don’t give you the level of resolution that the IsoPlexis platform can provide.”
Director of Translational Sciences at Kite
“The ability of the IsoLight to provide detailed analyses from very few cells is key, given that we are limited to small sample quantities of blood.”
Associate Professor of Immunology at Karolinska Institute
“MD Anderson, IsoPlexis Link T-Cell Functionality to Immunotherapy Response in AML.”
“We see potential in utilizing IsoPlexis’ single-cell system to help provide deeper resolution into the functional impacts of our therapeutics… This collaboration will enable us to apply the sensitivity of this solution to further our understanding of patient-specific responses to our immune therapies.”
Chief Scientific Officer, Nektar Therapeutics
“The ability to easily perform single-cell proteomics provides a way to understand the complexity of the cellular response to immunotherapy and then to design and test new therapies to enhance efficacy.”
Director, Center for Synthetic Immunity, Professor, Geisel School of Medicine, Dartmouth College
“Through this research, we were able to highlight the important role a functionally versatile subpopulation of CAR-T cells may play in the fight against cancer. This could lead to new methods to optimize T-cell products.”
Vice President, Translation Sciences, Kite
“The best way to predict the
future is to invent it.”
